col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


15 Results       Page 1

 [1] 
Wiley: Cell Biochemistry and Function
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2026―Mar―08 Neutrophils in Coronavirus Disease 2019: Guardians or Triggers of Immunopathology? Fatemeh Mohammadi Henjeroei, Niloufar Nosratabadi, Hossein Pourghadamyari, Akbar Anaeigoudari, Farnaz Sedghy, Reza Nosratabadi
2 [GO] 2024―May―16 1,25-Dihydroxyvitamin D3 attenuates platelet aggregation potentiated by SARS-CoV-2 spike protein via inhibiting integrin αIIbβ3 outside-in signaling Ruijie Wang, Zezhong Tian, Caixia Wang, Bingying Zhang, Meiyan Zhu, Yan Yang
3 [GO] 2023―Nov―10 COVID-19-associated liver injury: Adding fuel to the flame Yingqian Wang, Min Shen, Yujia Li, Jiangjuan Shao, Feng Zhang, Mei Guo, Zili Zhang, Shizhong Zheng
4 [GO] 2023―May―03 Laboratory methods: A concise review and update for COVID-19 diagnosis Mohadeseh Nemati, Ameneh Jafari, Yaser Ebrahimi, Ali Golchin, Fahima Danesh Pouya, Mostafa Rezaei-Tavirani, Yousef Rasmi
5 [GO] 2023―Mar―17 Acid sphingomyelinase (ASM) and COVID-19: A review of the potential use of ASM inhibitors against SARS-CoV-2 Pedro José Tronco Pauletto, Cassia Pereira Delgado, João Batista Teixeira da Rocha
6 [GO] 2022―Dec―15 Molecular modeling of C1-inhibitor as SARS-CoV-2 target identified from the immune signatures of multiple tissues: An integrated bioinformatics study Karthik Sekaran, Rinku Polachirakkal Varghese, R. Gnanasambandan, G. Karthik, I. Ramya, C. George Priya Doss
7 [GO] 2022―Dec―07 Potential targets of severe acute respiratory syndrome coronavirus 2 of clinical drug fluvoxamine: Docking and molecular dynamics studies to elucidate viral action Saroj Kumar Panda, Parth Sarthi Sen Gupta, Malay Kumar Rana
8 [GO] 2022―Oct―07 Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight Rahul Singh, Vijay K. Bhardwaj, Rituraj Purohit
9 [GO] 2022―Aug―18 Systemic redox imbalance in severe COVID-19 patients Isabelle A. L. Postiga, Paula C. Teixeira, Carla Andretta Moreira Neves, Paulo Santana Filho, Bruna Marmett, Roseana Carvalho, Alessandra Peres, Liane Rotta, Claudia Elizabeth Thompson, Gilson P. Dorneles, Pedro R. T. Romão
10 [GO] 2022―Jul―14 NK cell dysfunction is linked with disease severity in SARS-CoV-2 patients Khadijeh Dizaji Asl, Zeinab Mazloumi, Ghazal Majidi, Hossein Kalarestaghi, Shahnaz Sabetkam, Ali Rafat
11 [GO] 2022―Jun―01 Application of exosomes for the alleviation of COVID-19-related pathologies Aysa Rezabakhsh, Mahdi Mahdipour, Alireza Nourazarian, Paria Habibollahi, Emel Sokullu, Çigir Biray Avci, Reza Rahbarghazi
12 [GO] 2020―Dec―15 Nano-based methods for novel coronavirus 2019 ( 2019-nCoV ) diagnosis: A review Vahid Rahimkhoei, Jafar Rezaie, Ali Akbari, Aynaz Nourani, Nassrollah Jabbari, Zohreh Mehri Lighvan, Mojtaba Amini
13 [GO] 2020―Nov―03 Is there a link between vitamin D status, SARS-CoV -2 infection risk and COVID -19 severity? Davide Ferrari, Massimo Locatelli, Matteo Briguglio, Giovanni Lombardi
14 [GO] 2020―Sep―29 SARS-COV -2 ( COVID -19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments Hakan Parlakpinar, Mehmet Gunata
15 [GO] 2020―Aug―28 Potential small-molecule drugs as available weapons to fight novel coronavirus ( 2019-nCoV ): A review Vahid Rahimkhoei, Nassrollah Jabbari, Aynaz Nourani, Sina Sharifi, Ali Akbari
 [1] 

15 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec